Lehmann, Sylvain http://orcid.org/0000-0001-6117-562X
Dumurgier, Julien
Ayrignac, Xavier
Marelli, Cecilia
Alcolea, Daniel
Ormaechea, Juan Fortea
Thouvenot, Eric
Delaby, Constance
Hirtz, Christophe
Vialaret, Jérôme
Ginestet, Nelly
Bouaziz-Amar, Elodie
Laplanche, Jean-Louis
Labauge, Pierre
Paquet, Claire
Lleo, Alberto
Gabelle, Audrey
,
Funding for this research was provided by:
Association France Alzheimer (2018)
Ministère de l'Éducation Nationale (Plan ALzheimer)
Alzheimer's Disease Neuroimaging Initiative (NA)
Article History
Received: 3 June 2020
Accepted: 23 September 2020
First Online: 2 October 2020
Ethics approval and consent to participate
: All the patients at each clinical center gave their written informed consent to participating in clinical research on CSF biomarkers, which was approved by the respective Ethics Committees. The committee responsible in Montpellier was the regional Ethics Committee of the Montpellier University Hospital and Montpellier CSF-Neurobank #DC-2008-417 at the certified NFS 96-900 CHU resource center BB-0033-00031, ExternalRef removed. Authorization to handle personal data was granted by the French Data Protection Authority (CNIL) under the number 1709743 v0.
: Not applicable.
: The authors report no conflict of interest to disclose.